Thursday, June 11

Browsing: SacTMT

Diagnosis

Sac-TMT Combo Improves PFS vs Pembrolizumab in NSCLC

By NewsCancerMay 29, 20260

Progression-free survival (PFS) significantly improved when combining first-line sacituzumab tirumotecan (sac-TMT) with pembrolizumab (Keytruda) vs pembrolizumab alone among those with…

Treatments

Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer

By NewsCancerMay 18, 20260

Sacituzumab tirumotecan (sac-TMT) has become the first TROP2 antibody-drug conjugate (ADC) to demonstrate a statistically significant and clinically meaningful improvement…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Browsing: SacTMT

Sac-TMT Combo Improves PFS vs Pembrolizumab in NSCLC

Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

Latest Post

75 Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer: Real-World Treatment Patterns and Outcomes From Community Oncology Settings

Combination of paricalcitol with chemotherapy shows promise in phase 1 study of metastatic pancreatic cancer

Asciminib May Offer Longer, Better Life in Frontline CML Care

Subscribe to Updates

What's Hot

Browsing: SacTMT